|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities | ||||||||||||||||||||
| Marketable equity securities, at fair value | ||||||||||||||||||||
| Available for sale investment securities, at fair value | ||||||||||||||||||||
| Held to maturity investment securities, at amortized cost (fair values of $30,814 and $31,045 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Loans receivable (net of ACL-Loans of $30,627 at June 30, 2026 and $30,705 at December 31, 2025, respectively) | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Federal Home Loan Bank stock, at cost | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest bearing deposits | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from the Federal Home Loan Bank | ||||||||||||||||||||
| Subordinated debentures (face value of $70,000 and $70,000 at June 30, 2026 and December 31, 2025, respectively, less unamortized debt issuance costs of $180 and $303 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Common stock, no par value; 10,000,000 shares authorized, 7,973,180 and 7,899,943 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
